Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Objective: The objective of this research is to examine renal cancer nephrectomies over 25 years in our centre andthe factors underlying changes in disease-specific survival. Patients and methods: Retrospective data analysis was performed on all patients undergoing nephrectomies at ourinstitution for renal cell carcinoma (RCC) from 1983 to 2007. Data extracted from the Cancer Research Uro-OncologyDatabase (CRUD©) provided survival, clinical and prognostic information including tumour diameter, Fuhrman grade, WHO staging and age. Results: Analysis of 664 RCCs demonstrated a clear change in kidney cancer-specific survival over the past 25 years,with five-year survival improving from 42% (1983-1986) to 73% (1999-2002). The number of RCC nephrectomieshas increased 10 fold. There was no significant change in operative mortality, age, grade, stage or mean tumour size.However, there was a five-fold increase in tumours <6 cm, corresponding to an equal-fold decrease in tumours 6-8 cm,but no change in tumours >8 cm. Tumour size <8 cm was a significant adverse prognostic marker. Conclusions: A 30% improvement in RCC cancer-specific survival has been seen in our centre over the last 25 years. This change relates to a shift to smaller tumours, lower histological grades and a higher volume of cases. © British Association of Urological Surgeons 2013.

Original publication




Journal article


Journal of Clinical Urology

Publication Date





119 - 124